Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-20,188
Closed -$2.07M 467
2026
Q1
$2.07M Sell
20,188
-926
-4% -$105K 0.18% 63
2025
Q4
$2.65M Sell
21,114
-324
-2% -$41.3K 0.21% 51
2025
Q3
$2.87M Buy
+21,438
New +$2.81M 0.23% 45
2025
Q2
Sell
-22,173
Closed -$2.94M 389
2025
Q1
$2.94M Sell
22,173
-1,995
-8% -$254K 0.27% 43
2024
Q4
$2.73M Buy
24,168
+3,876
+19% +$448K 0.19% 50
2024
Q3
$2.31M Sell
20,292
-619
-3% -$67.9K 0.17% 63
2024
Q2
$2.17M Sell
20,911
-1,186
-5% -$126K 0.17% 59
2024
Q1
$2.51M Sell
22,097
-3,582
-14% -$411K 0.2% 55
2023
Q4
$2.83M Buy
+25,679
New +$2.57M 0.23% 47

Other funds holding ABT

Trust Point Inc's ABT Position: Q2 2026 in Review

Trust Point Inc sold out of Abbott (ABT) in Q2 2026, closing a stake of 20,188 shares — an estimated $2.07M sold.

Trust Point Inc first reported a position in ABT in Q4 2023 and held it in 9 quarters. The position peaked at $2.94M in Q1 2025. 940 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Trust Point Inc reported no remaining Abbott position as of Q2 2026 after selling out during the quarter.
  • Trust Point Inc sold 20,188 Abbott shares in Q2 2026, an estimated $2.07M.
  • Trust Point Inc first reported a position in Abbott in Q4 2023 and held it in 9 quarters.
  • Trust Point Inc's Abbott position peaked at $2.94M in Q1 2025.
  • 940 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Trust Point Inc's 13F filing for Q2 2026, filed 8 Jul 2026.